These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11748041)

  • 21. [Hemodynamics of cerebral circulation in local brain blood flow disorders].
    Betz E
    Med Welt; 1969 Jan; 2():69-74. PubMed ID: 5765492
    [No Abstract]   [Full Text] [Related]  

  • 22. Aspirin and ACE-inhibitors: for wedding or funeral?
    Barbash IM; Gottlieb S; Goldbourt U; Behar S; Leor J
    J Thromb Thrombolysis; 2001 Apr; 11(2):163-9. PubMed ID: 11406732
    [No Abstract]   [Full Text] [Related]  

  • 23. Vasodilating mechanisms of levosimendan: involvement of K+ channels.
    Yildiz O
    J Pharmacol Sci; 2007 May; 104(1):1-5. PubMed ID: 17452812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacology of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine, a new peripheral vasodilator agent].
    Popendiker K; Boksay I; Bollmann V
    Arzneimittelforschung; 1971 Aug; 21(8):1160-71. PubMed ID: 4329076
    [No Abstract]   [Full Text] [Related]  

  • 25. Isradipine improves endothelium-dependent vasodilation in normotensive coronary artery disease patients with hypercholesterolemia.
    Bracht C; Yan XW; Brunner-LaRocca HP; Sütsch G; Amann FW; Kiowski W
    J Hypertens; 2001 May; 19(5):899-905. PubMed ID: 11393673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelium-derived nitric oxide mediates hypoxic vasodilation of resistance vessels in humans.
    Blitzer ML; Lee SD; Creager MA
    Am J Physiol; 1996 Sep; 271(3 Pt 2):H1182-5. PubMed ID: 8853358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Vasodilation therapy in severe cardiac insufficiency. A review and therapeutic proposals without invasive hemodynamic monitoring].
    Sørensen JN; Godtfredsen J
    Ugeskr Laeger; 1981 Oct; 143(43):2792-6. PubMed ID: 7324227
    [No Abstract]   [Full Text] [Related]  

  • 28. Discussion on the search for an ideal vasodilator: a hemodynamic perspective.
    Julius S
    J Cardiovasc Pharmacol; 1987; 10 Suppl 1():S149-53. PubMed ID: 2442508
    [No Abstract]   [Full Text] [Related]  

  • 29. [Therapy of heart failure with vasodilator agents].
    Just H; Drexler H; Holubarsch C
    Z Kardiol; 1988; 77 Suppl 5():97-101. PubMed ID: 3066044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac, hemodynamic and renal functions in congestive heart failure during induced peripheral vasodilatation; relationship to Starling's law of the heart in man.
    SOBOL BJ; KESSLER RH; RADER B; EICHNA LW
    J Clin Invest; 1959 Mar; 38(3):557-78. PubMed ID: 13641407
    [No Abstract]   [Full Text] [Related]  

  • 31. Measures of vascular reactivity: prognostic crystal ball or Pandora's box?
    Minson CT; Green DJ
    J Appl Physiol (1985); 2008 Aug; 105(2):398-9. PubMed ID: 18556427
    [No Abstract]   [Full Text] [Related]  

  • 32. Vascular and neural mechanisms of ACh-mediated vasodilation in the forearm cutaneous microcirculation.
    Berghoff M; Kathpal M; Kilo S; Hilz MJ; Freeman R
    J Appl Physiol (1985); 2002 Feb; 92(2):780-8. PubMed ID: 11796692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coronary vasodilator reserve in primary and secondary left ventricular hypertrophy. A study with positron emission tomography.
    Choudhury L; Rosen SD; Patel D; Nihoyannopoulos P; Camici PG
    Eur Heart J; 1997 Jan; 18(1):108-16. PubMed ID: 9049522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review about "Androgen-induced vasorelaxation: a potential vascular protective effect" by M. Perusquía--Exp Clin Endocrinol Diabetes 2003; 111: 55-59.
    Zitzmann M; Nieschlag E
    Exp Clin Endocrinol Diabetes; 2003 Jun; 111(4):232-3. PubMed ID: 12845563
    [No Abstract]   [Full Text] [Related]  

  • 35. Brachial flow-mediated vasodilator responses in population-based research: methods, reproducibility and effects of age, gender and baseline diameter.
    Herrington DM; Fan L; Drum M; Riley WA; Pusser BE; Crouse JR; Burke GL; McBurnie MA; Morgan TM; Espeland MA
    J Cardiovasc Risk; 2001 Oct; 8(5):319-28. PubMed ID: 11702039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypercapnia-induced cerebral and ocular vasodilation is not altered by glibenclamide in humans.
    Bayerle-Eder M; Wolzt M; Polska E; Langenberger H; Pleiner J; Teherani D; Rainer G; Polak K; Eichler HG; Schmetterer L
    Am J Physiol Regul Integr Comp Physiol; 2000 Jun; 278(6):R1667-73. PubMed ID: 10848537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced constrictor reactivity balances impaired vasodilation in the mesenteric circulation of the obese Zucker rat.
    Romanko OP; Stepp DW
    Am J Physiol Heart Circ Physiol; 2005 Nov; 289(5):H2097-102. PubMed ID: 15951349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelial vasodilator function is related to low-density lipoprotein particle size and low-density lipoprotein vitamin E content in type 1 diabetes.
    Skyrme-Jones RA; O'Brien RC; Luo M; Meredith IT
    J Am Coll Cardiol; 2000 Feb; 35(2):292-9. PubMed ID: 10676672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dilated conjunctival vessels in a patient undergoing epoprostenol therapy.
    Foroozan R; Chan-Kai B; Marx DP
    Clin Exp Ophthalmol; 2007 Dec; 35(9):877-8. PubMed ID: 18173425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of baseline vasodilation on adrenergic reactions of systemic hemodynamics.
    Osadchii LI; Balueva TV; Sergeev IV
    Bull Exp Biol Med; 2003 Jun; 135(6):530-3. PubMed ID: 12937664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.